MV
Manuela Valente
Chief People Officer

Manuela Valente insider trades: SOPHiA GENETICS (SOPH) stock sales

Chief People Officer, SOPHiA GENETICS Last trade Oct 5, 2026 9 Form 4 filings
$182K
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2026
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Manuela reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 5, 2026SOPH↓ Sell10b5-1$34K
Aug 19, 2026SOPH↓ Sell10b5-1$79K
Jul 6, 2026SOPH↓ Sell10b5-1$21K
May 19, 2026SOPH↓ Sell10b5-1$2K
Apr 8, 2026SOPH↓ Sell10b5-1$19K
Apr 7, 2026SOPH↓ Sell10b5-1$24K
Mar 19, 2026SOPH↓ Sell10b5-1$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SOPH insiders

Open-market trades in the last 12 months

About Manuela Valente's insider trades

Manuela Valente is Chief People Officer at SOPHiA GENETICS (SOPH). Since Mar 19, 2026, Manuela has reported no open-market purchases and 7 sales worth $182K on SEC Form 4. In the last 12 months: 7 sales ($182K).

7 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SOPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.